VEGFA and breast neoplasm: Additionally, bevacizumab, an angiogenesis inhibitor against vascular endothelial growth factor (VEGF) was directly used as a targeting ligand to modify magnetic iron oxide nanoparticles (IONPs), which was demonstrated to be an efficient platform for bevacizumab delivery in mice breast tumor (4T1) treatment 58.